News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
SIOP’s first DiSPLeN webinar on Low-Grade Glioma
SIOP/LinkedIn
Dec 1, 2024, 15:20

SIOP’s first DiSPLeN webinar on Low-Grade Glioma

International Society of Paediatric Oncology – SIOP posted on LinkedIn:

“Join us for the first DiSPLeN webinar on Low-Grade Glioma on Dec 6, 2024, at 15:00 CET! Enhance your knowledge on childhood cancer care in low-resource settings. Don’t miss out, open to everyone – register today!”

SIOP

cancer OncoDaily Oncology SIOP
Special Coverage
Blog
Jul 26, 2025, 22:05
SIOPE and EURORDIS-Rare Diseases Europe Call for the Introduction of a Dedicated "First-in-Child" Incentive in the Legislative Text
Blog
Jul 26, 2025, 21:46
Sendurai Mani: From Student to Speaker - My Journey Back to IISc
Insight
Jul 26, 2025, 21:30
Yan Leyfman: Managing Infection Risk in Myeloma - Time to Rethink IgRT?
Blog
Jul 26, 2025, 21:09
Ammira Al-Shabeeb: Travel Award Applications are Now Open for PMFG Summit 2025
Opinion
Jul 26, 2025, 20:53
Patrick Hwu: Sarcoma is Rare and Complex
Blog
Jul 26, 2025, 20:13
Ready to Take Your Cancer Research Career to the Next Level? - EACR
Blog
Jul 26, 2025, 20:00
EU’s Medicine Strategy is Focused on Supply Chains, But Overlooks the Deeper Risk
Blog
Jul 26, 2025, 19:45
Siddharth Sreemahadevan: I was Honored to Be Declared Second Runner-Up in the 8th SPEAK Lymphoma Programme
Opinion
Jul 26, 2025, 19:31
The AACR Immuno-Oncology Research Fellowships Provide $130,000 to Support Clinical Fellows
Blog
Jul 26, 2025, 19:14
Bishal Gyawali: Calling the Family of My Patients After They Have Passed Away - It’s the Least We Can Do
Science
Jul 26, 2025, 18:38
Incorporating Evidence-Based Approaches for Patients With GI Cancers - Society for Integrative Oncology
Insight
Jul 26, 2025, 18:15
Medicinal Cannabis for Symptom Control in Advanced Cancer - MASCC